ECM
CRDF icon

Element Capital Management’s Cardiff Oncology CRDF Stock Holding History

Element Capital Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,828
Closed -$166K – 73
2017
Q2 		$166K Buy
+1,828
New +$118K 0.03% 104

Other funds holding CRDF

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $117M AUM 28.12% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Element Capital Management's CRDF Position: Q3 2017 in Review

Element Capital Management sold out of Cardiff Oncology (CRDF) in Q3 2017, closing a stake of 1,828 shares — an estimated $166K sold.

Element Capital Management first reported a position in CRDF in Q2 2017 and held it in 1 quarter. The position peaked at $166K in Q2 2017. 47 funds tracked by Wall St. Rank hold CRDF as of Q3 2017.

  • Element Capital Management reported no remaining Cardiff Oncology position as of Q3 2017 after selling out during the quarter.
  • Element Capital Management sold 1,828 Cardiff Oncology shares in Q3 2017, an estimated $166K.
  • Element Capital Management first reported a position in Cardiff Oncology in Q2 2017 and held it in 1 quarter.
  • Element Capital Management's Cardiff Oncology position peaked at $166K in Q2 2017.
  • 47 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2017.

Based on Element Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.